BMY News
-
BMY neutral
Bristol Myers Squibb: Still Cheap, Despite What The Chart Says (NYSE:BMY)
seekingalpha.com·Sep 4, 2026·Sure enough, Bristol Myers Squibb ( BMY ) has turned out to be a lovely hedge to offset AI-heavy portfolio risk so far. As things stand, the pharma behemoth has...
-
BMY bullish
Bristol Myers Squibb: Buy The Growth Portfolio At A Value Price (NYSE:BMY)
seekingalpha.com·Sep 4, 2026·iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity f...
-
BMY neutral
2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
finance.yahoo.com·Sep 2, 2026·Dividend stocks can be tricky for investors. If you're looking to invest $1,000 and benefit from a stock that pays a dividend, you have to look past the stock's...
-
BMY neutral
NVS Looks 16.5% Overvalued on GF Value™ Amid Dividend Safety Focus
gurufocus.com·Sep 1, 2026·On September 01, 2026, Novartis AG (NYSE: NVS) announced a pause in eight clinical trials involving an experimental therapy for autoimmune and neurological diso...
-
BMY bearish
Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast
insidermonkey.com·Aug 21, 2026·Hims & Hers Health, Inc. (NYSE:HIMS) shares fell over 2% on Tuesday even after the telehealth company posted second-quarter revenue of $753.2 million, up 38% an...
-
BMY neutral
BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
manilatimes.net·Aug 20, 2026·Pumitamig plus B7H3-targeting elfetabart drozuntecan delivers the first data in lung cancer for any PD-(L)1xVEGF bispecific immunomodulator combined with an ant...
-
BMY neutral
AstraZeneca Vs. Bristol-Myers Squibb: Who’s The Better Bargain For Investors (NYSE:BMY)
seekingalpha.com·Aug 19, 2026·With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conser...
-
BMY neutral
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
finance.yahoo.com·Aug 18, 2026·Want some quality dividend stocks to buy, but don't want to break the bank? The stocks listed below offer above-average yields and trade at less than $100. They...
-
BMY neutral
US Pharma Firms Forge Deals with Chinese Biotechs Amid Regulatory Pushback
chinamoneynetwork.com·Aug 17, 2026·This area is available only to Subscribers. Major US pharmaceutical companies are accelerating partnerships with Chinese biotech firms despite efforts to decou...
-
BMY bearish
BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market
rttnews.com·Aug 4, 2026·Tuesday, BioNTech SE (BNTX) announced its financial results for the second quarter, reporting a net loss of 820.8 million euros, or 3.24 euros per share, compar...
-
BMY bullish
Bristol-Myers Squibb Stock: Why I'm Still Bullish After Q2 (NYSE:BMY)
seekingalpha.com·Jul 30, 2026·With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conser...
-
BMY neutral
Gyre Therapeutics Appoints Three New Members to its Board of Directors
manilatimes.net·Jul 16, 2026·SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. ("Gyre”, "Gyre Therapeutics” or the "Company”) (Nasdaq: GYRE), an innovative, commerc...
-
BMY neutral
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
finance.yahoo.com·Jul 14, 2026·Drug pricing has been hanging over the pharmaceutical industry for years, and the Trump administration didn't eliminate that pressure. It did, however, pursue v...
-
BMY neutral
Bristol-Myers Squibb’s Q2 2026 Earnings: What to Expect
finance.yahoo.com·Jul 9, 2026·Bristol Myers Squibb logo under a magnifying glass_ By Casimiro With a market cap of $117.5 billion, Bristol-Myers Squibb Company (BMY) is a global biopharmace...
-
BMY neutral
Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.
finance.yahoo.com·Jul 6, 2026·Bristol Myers Squibb (NYSE: BMY) belongs to an elite group. Only two other large-cap healthcare stocks offer higher dividend yields. Bristol Myers Squibb's juic...